Hot Pursuit     18-Jul-22
NIIT Ltd leads losers in 'A' group
Bhansali Engineering Polymers Ltd, Zydus Lifesciences Ltd, EPL Ltd and Laurus Labs Ltd are among the other losers in the BSE's 'A' group today, 18 July 2022.

Bhansali Engineering Polymers Ltd, Zydus Lifesciences Ltd, EPL Ltd and Laurus Labs Ltd are among the other losers in the BSE's 'A' group today, 18 July 2022.

NIIT Ltd tumbled 7.28% to Rs 352.75 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 1.12 lakh shares were traded on the counter so far as against the average daily volumes of 28981 shares in the past one month.

Bhansali Engineering Polymers Ltd lost 4.81% to Rs 106.9. The stock was the second biggest loser in 'A' group.On the BSE, 1.61 lakh shares were traded on the counter so far as against the average daily volumes of 50339 shares in the past one month.

Zydus Lifesciences Ltd crashed 3.44% to Rs 358.4. The stock was the third biggest loser in 'A' group.On the BSE, 1.61 lakh shares were traded on the counter so far as against the average daily volumes of 32623 shares in the past one month.

EPL Ltd dropped 3.07% to Rs 176.95. The stock was the fourth biggest loser in 'A' group.On the BSE, 18644 shares were traded on the counter so far as against the average daily volumes of 10543 shares in the past one month.

Laurus Labs Ltd fell 3.00% to Rs 506.85. The stock was the fifth biggest loser in 'A' group.On the BSE, 53981 shares were traded on the counter so far as against the average daily volumes of 54393 shares in the past one month.

Previous News
  NIIT allots 19,998 equity shares under ESOP
 ( Corporate News - 26-Jul-24   15:18 )
  NIIT to conduct board meeting
 ( Corporate News - 24-Jul-24   10:30 )
  Zydus receives USFDA approval for Valsartan Tablets
 ( Corporate News - 23-Jul-24   15:20 )
  Indices trade with moderate losses; PSU bank shares decline
 ( Market Commentary - Mid-Session 23-Jul-24   14:31 )
  Zydus Life gets final approval from USFDA for hypertension drug
 ( Hot Pursuit - 23-Jul-24   12:10 )
  Zydus Lifes gains after receiving approval from COFEPRIS for Bevacizumab biosimilar
 ( Hot Pursuit - 22-Jul-24   11:00 )
  Zydus receives Mexican regulatory approval for cancer drug - Bhavaâ„¢
 ( Corporate News - 22-Jul-24   09:09 )
  Zydus' transdermal manufacturing site completes USFDA inspection
 ( Corporate News - 19-Jul-24   19:26 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
  Zydus Life gets USFDA nod for Zituvimet XR tablets
 ( Hot Pursuit - 19-Jul-24   11:53 )
  Zydus Life Vadodara unit gets OAI report from USFDA
 ( Hot Pursuit - 19-Jul-24   09:49 )
Other Stories
  Power Grid Q1 PAT rises 3% YoY to Rs 3,724 cr
  27-Jul-24   08:54
  IndusInd Bank PAT rises to Rs 2,152 cr in Q1 FY25
  26-Jul-24   17:40
  Cipla spurts as Q1 PAT rises 18% YoY to Rs 1,178 cr
  26-Jul-24   15:53
  Shriram Finance soars as Q1 PAT rises 18% YoY
  26-Jul-24   15:33
  Indus Towers spurts on buyback plan
  26-Jul-24   15:28
  MMTC Ltd leads losers in 'A' group
  26-Jul-24   15:00
  Nova Agritech Ltd leads losers in 'B' group
  26-Jul-24   14:45
  Volumes soar at New India Assurance Company Ltd counter
  26-Jul-24   14:30
  Piramal Pharma Q1 net loss narrows to Rs 89 crore
  26-Jul-24   14:28
  Mphasis spurts as Q1 PAT rises 3% QoQ to Rs 405 cr
  26-Jul-24   14:10
Back Top